# Press Releases & Media Statements

**July 15, 2026**

### Innovation and growth drive first-half 2026 performance

[Read more](/content/us/media/press-releases/innovation-and-growth-drive-first-half-2026-performance "Read more about \"Innovation and growth drive first-half 2026 performance\""/index.html)

**June 30, 2026**

### Boehringer Ingelheim and Missouri Western State University Introduce New Bio-Process Certificate Program

[Read more](/content/us/animal-health/our-responsibility/boehringer-ingelheim-missouri-western-state-university-bio-process-certificate-program "Read more about \"Boehringer Ingelheim and Missouri Western State University Introduce New Bio-Process Certificate Program\""/index.html)

**June 22, 2026**

### Boehringer advances three Phase III trials in oncology

[Read more](/content/us/human-health/cancer/across-cancer-types/boehringer-advances-three-phase-iii-trials-oncology "Read more about \"Boehringer advances three Phase III trials in oncology\""/index.html)

**June 07, 2026**

### Full data from two Phase III SYNCHRONIZE obesity trials

[Read more](/content/us/human-health/metabolic-diseases/positive-data-two-phase-iii-synchronize-obesity-trials "Read more about \"Full data from two Phase III SYNCHRONIZE obesity trials\""/index.html)

**May 21, 2026**

### New research across Boehringer’s oncology portfolio will be presented at ASCO 2026

[Read more](/content/us/human-health/cancer/across-cancer-types/boehringer-presents-data-across-oncology-portfolio-asco "Read more about \"New research across Boehringer’s oncology portfolio will be presented at ASCO 2026\""/index.html)

**April 28, 2026**

### Results from Phase III SYNCHRONIZE-1 obesity trial

[Read more](/content/us/human-health/metabolic-diseases/results-phase-iii-synchronize-1-obesity-trial "Read more about \"Results from Phase III SYNCHRONIZE-1 obesity trial\""/index.html)

**April 23, 2026**

### The Atlanta Braves and Boehringer Ingelheim unveil 2026 “Dogout” to honor veterinarians

[Read more](/content/us/animal-health/our-responsibility/atlanta-braves-and-boehringer-ingelheim-unveil-2026-dogout-honor-veterinarians "Read more about \"The Atlanta Braves and Boehringer Ingelheim  unveil 2026 “Dogout” to honor veterinarians\""/index.html)

**April 16, 2026**

### Study results for patients with HER2-mutant NSCLC published in NEJM

[Read more](/content/us/human-health/cancer/lung-cancer/nejm-publishes-results-patients-her2-mutant-nsclc "Read more about \"Study results for patients with HER2-mutant NSCLC published in NEJM\""/index.html)

**April 09, 2026**

### Boehringer and Click announce CT-155 funding and investment

[Read more](/content/us/human-health/mental-health/schizophrenia/boehringer-and-click-announce-ct-155-funding-and-investment "Read more about \"Boehringer and Click announce CT-155 funding and investment\""/index.html)

**April 06, 2026**

### Boehringer Ingelheim’s Athens Site Achieves Carbon Neutral Operations, Advancing 2030 Commitments

[Read more](/content/us/media/press-releases/boehringer-ingelheim-athens-site-achieves-carbon-neutral-operations "Read more about \"Boehringer Ingelheim’s Athens Site Achieves Carbon Neutral Operations, Advancing 2030 Commitments\""/index.html)

**April 02, 2026**

### Boehringer Ingelheim launches STEM Innovation Lab in CT

[Read more](/content/us/media/press-releases/boehringer-ingelheim-launches-stem-innovation-lab-ct "Read more about \"Boehringer Ingelheim launches STEM Innovation Lab in CT\""/index.html)

**March 25, 2026**

### Boehringer Ingelheim reports 2025 growth and pipeline progress

[Read more](/content/us/media/press-releases/boehringer-ingelheim-reports-2025-growth-and-pipeline-progress "Read more about \"Boehringer Ingelheim reports 2025 growth and pipeline progress\""/index.html)